The scientists are doing the work for the Metrics Division which is contributing a huge profit to MYX. Also some of the manufacturing is flowing from the approved product that the scientists are dealing with. This type of outsourcing is "the way it is being done" by many companies, per my information. some the recommended companies are totally involved in doing what MYX Metrics Division does.
When you lose as much as they did buying the Teva generics it was always going to take 5 years to recover and turn the ship in another direction. Its starting to motor quite well now. IQVIA stating that the Nextstellis prescriptions are the fastest growing in 2022 is great news. If they were not the fastest growing we would be upset. Now that they are the fastest should be giving us some encouragement.
Ann: Mayne Pharma appoints new CFO, page-16
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.72 |
Change
0.040(0.85%) |
Mkt cap ! $401.5M | |||
| Open | High | Low | Value | Volume |
| $4.68 | $4.77 | $4.68 | $560.3K | 118.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 107 | $4.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.75 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |